246 related articles for article (PubMed ID: 25595260)
21. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
Begolka WS; Vanderlugt CL; Rahbe SM; Miller SD
J Immunol; 1998 Oct; 161(8):4437-46. PubMed ID: 9780223
[TBL] [Abstract][Full Text] [Related]
22. Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS).
Constantinescu CS; Lavi E
Curr Eye Res; 2000 Jan; 20(1):71-6. PubMed ID: 10611718
[TBL] [Abstract][Full Text] [Related]
23. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
24. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Hammer LA; Zagon IS; McLaughlin PJ
Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
[TBL] [Abstract][Full Text] [Related]
25. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
26. Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete freund adjuvant.
Jagessar SA; Kap YS; Heijmans N; van Driel N; van Straalen L; Bajramovic JJ; Brok HP; Blezer EL; Bauer J; Laman JD; 't Hart BA
J Neuropathol Exp Neurol; 2010 Apr; 69(4):372-85. PubMed ID: 20448482
[TBL] [Abstract][Full Text] [Related]
27. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
28. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
29. The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
Polak PE; Lin SX; Pelligrino D; Feinstein DL
J Neuroimmunol; 2014 Nov; 276(1-2):135-41. PubMed ID: 25242632
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis.
Tonra JR; Reiseter BS; Kolbeck R; Nagashima K; Robertson R; Keyt B; Lindsay RM
J Comp Neurol; 2001 Jan; 430(1):131-44. PubMed ID: 11135250
[TBL] [Abstract][Full Text] [Related]
31. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
32. Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
Seo JE; Hasan M; Han JS; Kang MJ; Jung BH; Kwok SK; Kim HY; Kwon OS
J Neuroimmunol; 2015 Oct; 287():43-53. PubMed ID: 26439961
[TBL] [Abstract][Full Text] [Related]
33. Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus.
Breuer J; Korpos E; Hannocks MJ; Schneider-Hohendorf T; Song J; Zondler L; Herich S; Flanagan K; Korn T; Zarbock A; Kuhlmann T; Sorokin L; Wiendl H; Schwab N
J Neuroinflammation; 2018 Aug; 15(1):236. PubMed ID: 30134924
[TBL] [Abstract][Full Text] [Related]
34. Effects of exercise in a relapsing-remitting model of experimental autoimmune encephalomyelitis.
Klaren RE; Stasula U; Steelman AJ; Hernandez J; Pence BD; Woods JA; Motl RW
J Neurosci Res; 2016 Oct; 94(10):907-14. PubMed ID: 27312674
[TBL] [Abstract][Full Text] [Related]
35. Keratan sulfate exacerbates experimental autoimmune encephalomyelitis.
Ueno R; Miyamoto K; Tanaka N; Moriguchi K; Kadomatsu K; Kusunoki S
J Neurosci Res; 2015 Dec; 93(12):1874-80. PubMed ID: 26340909
[TBL] [Abstract][Full Text] [Related]
36. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
[TBL] [Abstract][Full Text] [Related]
37. Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease.
Blaber SI; Ciric B; Christophi GP; Bernett MJ; Blaber M; Rodriguez M; Scarisbrick IA
FASEB J; 2004 May; 18(7):920-2. PubMed ID: 15033932
[TBL] [Abstract][Full Text] [Related]
38. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
39. Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.
Mattner F; Staykova M; Berghofer P; Wong HJ; Fordham S; Callaghan P; Jackson T; Pham T; Gregoire MC; Zahra D; Rahardjo G; Linares D; Katsifis A
J Nucl Med; 2013 Feb; 54(2):291-8. PubMed ID: 23321458
[TBL] [Abstract][Full Text] [Related]
40. Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice.
Smith PA; Morris-Downes M; Heijmans N; Pryce G; Arter E; O'Neill JK; 't Hart B; Baker D; Amor S
J Neuroimmunol; 2005 Jul; 164(1-2):76-84. PubMed ID: 15927270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
